Clinical trial
Zmax Pediatric Vs Adult Concentration For The Treatment Of Acute Otitis Media
NCT00360100 · Pfizer, Industry · Completed
Key facts
| NCT number | NCT00360100 |
|---|---|
| Title | Zmax Pediatric Vs Adult Concentration For The Treatment Of Acute Otitis Media |
| Official title | A Randomized, Multicenter, Comparative Study To Assess Tolerability Of A Single Oral 60 Mg/Kg Dose Of Zmax (Pediatric Concentration) Vs. Zmax (Adult Concentration) In Pediatric Patients With Acute Otitis Media |
| Lead sponsor | Pfizer, Industry |
| Status | Completed |
| Phase | Phase 3 |
| Study type | Interventional |
| Conditions | Otitis Media |
| Intervention type | Drug |
| Interventions | Zmax |
| Enrollment | 120 |
| Start date | Aug 1, 2006 |
| Completion | Dec 1, 2006 |
| First posted | Aug 3, 2006 |
| Last update posted | May 17, 2011 |
| Countries | Argentina, Chile, Costa Rica, Dominican Republic, Guatemala, Panama, United States |
At a glance
- 10–99 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: